Skip to main content

Table 1 Clinical characteristics of subjects in this study

From: Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases

Parameter HC HHC CHB HBLC HCC
Number of subjects 78 41 77 63 61
Gender (male, %) 45 (57.6%) 29 (70.7%) 50 (64.9%) 47 (74.6%) 39 (63.9%)
Age (range, mean) 19–67, 42.1 17–59, 39 26–66, 45.3 32–68, 48.2 37–67, 53.5
ALT (U/L) 15.8 ± 7.43 16.3 ± 8.33 143.8 ± 144.1 46.11 ± 41.37 16.46 ± 6.56
AST (U/L) 17.98 ± 6.32 17.34 ± 7.91 173.1 ± 254.5 61.52 ± 79.3 21.5 ± 7.25
HBV DNA (log10 IU/mL) N/A 2.58 ± 0.69 5 ± 1.65 4.96 ± 1.7 4.97 ± 2.04
  1. For age, ALT, AST, HBV DNA titres, data are presented as mean ± SD
  2. N/A not available